Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.2883
+0.1173 (68.60%)
At close: Jan 30, 2026

Lipella Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1.862.183.295.121.410.61
Short-Term Investments
----0.3-
Cash & Short-Term Investments
1.862.183.295.121.710.61
Cash Growth
37.09%-33.67%-35.69%198.75%182.56%2233.15%
Other Receivables
-0.080.030.11-0.07
Receivables
-0.080.030.11-0.07
Prepaid Expenses
0.220.350.10.560.090.02
Total Current Assets
2.082.623.435.81.810.7
Property, Plant & Equipment
0.270.060.150.150.20.26
Total Assets
2.352.673.585.952.010.96
Accounts Payable
0.460.390.140.380.050.02
Accrued Expenses
0.140.320.160.460.230.11
Short-Term Debt
---0.280.030.03
Current Portion of Leases
0.040.050.090.060.040.05
Other Current Liabilities
-----0
Total Current Liabilities
0.640.750.391.180.340.21
Long-Term Debt
----0.050.05
Long-Term Leases
0.22-0.050.10.170.21
Other Long-Term Liabilities
----0.030.03
Total Liabilities
0.860.750.431.270.590.49
Common Stock
000000
Additional Paid-In Capital
20.7217.2613.4710.384.531.7
Retained Earnings
-19.23-15.34-10.32-5.7-3.11-1.24
Total Common Equity
1.491.923.144.681.420.46
Shareholders' Equity
1.491.923.144.681.420.46
Total Liabilities & Equity
2.352.673.585.952.010.96
Total Debt
0.260.050.140.430.280.33
Net Cash (Debt)
1.592.143.164.691.430.27
Net Cash Growth
24.07%-32.30%-32.71%227.80%420.77%-
Net Cash Per Share
0.522.044.219.243.361.03
Filing Date Shares Outstanding
4.622.550.780.720.480.48
Total Common Shares Outstanding
4.621.210.760.720.480.29
Working Capital
1.441.863.044.621.470.49
Book Value Per Share
0.321.594.166.512.941.61
Tangible Book Value
1.491.923.144.681.420.46
Tangible Book Value Per Share
0.321.594.166.512.941.61
Machinery
0.140.140.140.13--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.